Publication | Open Access
PD-1 inhibitors plus anti-angiogenic therapy with or without intensity-modulated radiotherapy for advanced hepatocellular carcinoma: A propensity score matching study
52
Citations
22
References
2022
Year
The combination of PD-1 inhibitors with anti-angiogenic therapy and IMRT for HCC is a promising regimen.
| Year | Citations | |
|---|---|---|
Page 1
Page 1